| 書(shū)目名稱 | Resistance to Anti-Cancer Therapeutics Targeting Receptor Tyrosine Kinases and Downstream Pathways |
| 編輯 | Yosef Yarden,Moshe Elkabets |
| 視頻video | http://file.papertrans.cn/829/828448/828448.mp4 |
| 概述 | Comprehensively covers the multiplicity and diversity of mechanisms underlying resistance to the currently approved drugs, both tyrosine kinase inhibitors and monoclonal antibodies, that specifically |
| 叢書(shū)名稱 | Resistance to Targeted Anti-Cancer Therapeutics |
| 圖書(shū)封面 |  |
| 描述 | .This volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance.. |
| 出版日期 | Book 2018 |
| 關(guān)鍵詞 | Anti-cancer; Kinases; Resistance; Tyrosine; therapeutics |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-319-67932-7 |
| isbn_softcover | 978-3-030-09817-9 |
| isbn_ebook | 978-3-319-67932-7Series ISSN 2196-5501 Series E-ISSN 2196-551X |
| issn_series | 2196-5501 |
| copyright | Springer International Publishing AG, part of Springer Nature 2018 |
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-20 21:56
發(fā)表于 2025-3-21 17:49:57
